Friday, May 30, 2008

FDA Announces Product Recall

International Pharmaceuticals, Ltd. has announced that they are conducting a voluntary product recall of their dietary supplement product known as Viril-Ity-Power (VIP) Tabs. The recall was announced as a result of the company being notified by the Food and Drug Administration (FDA) of a potentially harmful undeclared ingredient known as hydroxyhomosildenafil. The FDA believes that hydroxyhomosildenafil is an analog of sildenafil, which is an active ingredient for Erictile Dysfunction (ED). One concern is that there could be a harmful drug interaction with this product and the active ingredients in some prescription drugs. The VIP Tabs were sold nationwide. If you are using this product, you should discontinue immediately and contact a medical professional. The Company has advised that any unused portions of this product be returned to CB Distributors in Benoit, Wisconsin, (800)-273-4137, Ext. 3. Additional Information Pertaining to Defective and Dangerous Products

Friday, May 9, 2008

Medtronic Announces Recall

Medtronic, Inc. recently announced that they are initiating a recall. The recall is a voluntary one that is being taken as a precautionary measure relative to selected products that have the Carmeda BioActive surface. These particular devices are used for heart surgeries. Several different products have the Carmeda BioActive surface and are affected including oxygenators, reservoirs, pumps, cannulae, and tubing packs. Patent risk is unknown at the present time. However, the U.S. Food and Drug Administration (FDA) have received a substantial amount of reports of injury and deaths in patients who have been administered injectable heparin products containing high levels of OSCS. For further details, see full article.